IRIS PubliCatt

Salerno, Maria Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.511
EU - Europa 1.283
AS - Asia 418
AF - Africa 35
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.260
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.495
DE - Germania 490
SE - Svezia 214
CN - Cina 154
SG - Singapore 146
IT - Italia 129
UA - Ucraina 106
FR - Francia 71
IE - Irlanda 68
PL - Polonia 51
GB - Regno Unito 46
ID - Indonesia 42
IN - India 39
CI - Costa d'Avorio 32
FI - Finlandia 30
RU - Federazione Russa 21
BE - Belgio 13
CA - Canada 11
ES - Italia 11
IR - Iran 11
NL - Olanda 8
JP - Giappone 7
AT - Austria 6
HK - Hong Kong 5
MX - Messico 5
TR - Turchia 5
SI - Slovenia 4
VN - Vietnam 4
BR - Brasile 3
CL - Cile 3
CZ - Repubblica Ceca 3
EG - Egitto 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EC - Ecuador 2
LT - Lituania 2
SA - Arabia Saudita 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
HU - Ungheria 1
KR - Corea 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
Totale 3.260
Salva come PNG Salva come JPEG
Città #
Chandler 397
Ashburn 144
Singapore 112
New York 69
Dublin 67
San Mateo 61
Ann Arbor 56
Jacksonville 52
Milan 44
Wilmington 43
Jakarta 42
Fairfield 38
Nanjing 35
Abidjan 32
Boston 31
Dearborn 30
Nürnberg 30
Kraków 27
Houston 25
Redwood City 23
Lawrence 20
Princeton 20
Warsaw 20
Rome 19
Woodbridge 19
Moscow 18
Beijing 17
Brussels 13
Marseille 13
Los Angeles 12
Seattle 12
Chicago 10
Andover 9
Guangzhou 8
Leawood 8
Tianjin 8
Augusta 7
Boardman 7
Cattolica 7
Hangzhou 7
Hebei 7
Helsinki 7
Nanchang 7
Norwalk 7
Toronto 7
Zhengzhou 7
Pune 6
Shenyang 6
University Park 6
Bremen 5
Changchun 5
Costa Mesa 5
Frankfurt am Main 5
Fremont 5
Redmond 5
Tokyo 5
Bologna 4
Busto Arsizio 4
Changsha 4
Hong Kong 4
Izmir 4
Jiaxing 4
Kunming 4
London 4
Mexico 4
Romainville 4
San Diego 4
Santa Clara 4
Washington 4
Amsterdam 3
Bangalore 3
Detroit 3
Groningen 3
Hanoi 3
Lancaster 3
Mountain View 3
Munich 3
Ottawa 3
São Paulo 3
Vienna 3
Bolzano 2
Brno 2
Cambridge 2
Dallas 2
Esslingen am Neckar 2
Guayaquil 2
Haikou 2
Hefei 2
Izola 2
Jinan 2
Katowice 2
Kish 2
Kochi 2
Las Vegas 2
Ljubljana 2
Manchester 2
Monmouth Junction 2
Naples 2
Nuremberg 2
Paris 2
Totale 1.832
Salva come PNG Salva come JPEG
Nome #
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 237
Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion 140
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 123
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 122
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 121
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 114
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 100
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 97
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 96
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 96
Complete clinical remission of psoriasis 6 months after renal transplantation 93
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 93
Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a good balance between weight loss and complications, if compared with gastric bypass and biliopancreatic diversion 91
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 88
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 87
Significant improvement in patient survival after renal transplantation in the last decade. 86
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 86
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 85
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 80
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 74
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 73
Evolution of causes of mortality in renal transplantation in the last 10 years 72
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 72
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 71
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 70
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 69
[Organ transplantation: training and prospects for a young surgeon] 65
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 65
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 61
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 58
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 58
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 55
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 55
Radiofrequency thermal ablation of renal graft neoplasms: Case series and literature review 50
Thymoglobuline plus basiliximab a mixed cocktail to start? 50
Incidence of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients Immunosuppressed With Sirolimus in Combination With Cyclosporine 47
Are there any relations among transplant centre volume, surgical technique and anatomy for donor graft selection? Ten-year multicentric Italian experience on mini-invasive living donor nephrectomy 45
Cardiovascular Risk Profile in Kidney Transplant Recipients Treated With Two Immunosuppressive Regimens: Tacrolimus and Mycophenolate Mofetil Versus Everolimus and Low-Dose Cyclosporine 43
High-dose atorvastatin reduces oxidative stress of ischemia/reperfusion injury after isogeneic kidney transplantation in rats: in vivo, preclinical, case–control, open-label study 42
Higher Incidence of Acute Rejection in Renal Transplant Recipients With Low Everolimus Exposure 37
Elderly kidney transplant recipient with intermittent fever: A case report of leishmaniasis with acute kidney injury during liposomal amphotericin B therapy 19
Induction With Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study 17
Totale 3.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.013
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 0 0 0 0 0 0 39 5 24 12 63 40
2020/2021325 32 31 10 27 41 26 39 6 45 10 51 7
2021/2022400 14 31 7 15 17 9 16 69 16 29 74 103
2022/2023962 126 137 66 175 40 116 52 80 122 12 24 12
2023/2024398 23 97 7 44 15 89 17 26 7 10 29 34
2024/2025301 21 36 95 41 78 29 1 0 0 0 0 0
Totale 3.303